title: "Protecting Children from Mosquito Diseases in Europe" date: "2026-04-03" excerpt: "Children face unique risks from mosquito-borne diseases in Europe. Learn about age-specific dangers, vaccine limitations for under-12s, and physical barriers." category: "diseases" author: "Mosticare Editorial"

Protecting Children from Mosquito-Borne Diseases in Europe

By Mosticare Editorial | Published 2026-04-03

As mosquito-borne diseases become the "new normal" in Europe, parents face an increasingly urgent question: how do I protect my children? The ECDC and the WHO Regional Office for Europe specifically identify children as a vulnerable group requiring targeted protection. With vaccines either unavailable, restricted, or suspended for most mosquito-borne diseases, and chemical repellents posing their own concerns for young skin, physical barriers and environmental management have never been more important.

Why Children Are Especially Vulnerable

Immature Immune Systems

Children's immune systems are still developing, making them less able to mount an effective response to viral infections. Dengue, in particular, can be more severe in children. According to clinical literature on mosquito-borne diseases and their impact on children, paediatric dengue infections carry a higher risk of progressing to severe dengue (dengue haemorrhagic fever or dengue shock syndrome) compared with adult infections.

Higher Exposure

Children spend more time outdoors -- playing in gardens, parks, schoolyards, and playgrounds -- precisely during the hours when tiger mosquitoes (Aedes albopictus) are most active. Their smaller body surface area relative to adults also means a higher concentration of mosquito bites per kilogram of body weight.

Less Self-Protective Behaviour

Young children cannot independently take preventive measures. They do not apply their own repellent, are less likely to wear protective clothing in warm weather, and may not recognise or report mosquito bites. This makes parental vigilance and environmental measures critical.

Vulnerability to Specific Diseases

Vaccine Limitations for Children

One of the most concerning aspects of Europe's mosquito-borne disease landscape is the lack of vaccine options for children.

Dengue Vaccines

Qdenga (TAK-003) is approved by the European Medicines Agency but is indicated for individuals aged 4 years and older. It is not widely available for routine paediatric use in Europe, and its effectiveness varies by dengue serotype and prior infection status. Dengvaxia (the older vaccine) is restricted to individuals with prior confirmed dengue infection due to safety concerns, and is not recommended for seronegative children.

Chikungunya Vaccine

The IXCHIQ vaccine was approved for adults aged 18 and over. It was never authorised for use in children. Moreover, the vaccine has been suspended by the US FDA and restricted in Europe due to serious adverse events in adults, meaning no chikungunya vaccine is currently available for any age group.

West Nile Virus Vaccine

No vaccine exists for West Nile virus in humans of any age. Vaccine development has stalled at the clinical trial stage.

Zika Vaccine

No Zika vaccine has been approved for human use.

The Bottom Line

For the foreseeable future, European children have no reliable pharmaceutical protection against the mosquito-borne diseases circulating on the continent. This reality places the entire burden of prevention on bite avoidance and vector control.

The Case for Physical Barriers

Given the limitations of vaccines and the concerns about chemical repellents for young children, physical barriers represent the most effective, safest, and most sustainable approach to protecting children from mosquito-borne diseases.

Why Physical Barriers Excel for Children

Practical Physical Barrier Solutions

In the home:

In outdoor play areas:

For pushchairs and prams:

For travel:

Chemical Repellents: Age-Specific Guidance

When physical barriers are insufficient, repellents may be used with appropriate caution. The WHO advises following product-specific age recommendations. General guidance:

Important: Never apply repellent under clothing, and always wash repellent off when the child comes indoors.

Environmental Management: Every Family's Role

Eliminating mosquito breeding sites around your home is one of the most impactful actions any family can take. Tiger mosquitoes breed in tiny amounts of standing water -- as little as a bottlecap:

What Paediatricians Recommend

The consensus among European paediatric and public health authorities can be summarised in three priorities:

  1. Physical barriers first: Screens, nets, and protective clothing are the foundation of child protection.
  2. Environmental action: Eliminate breeding sites to reduce mosquito populations at the source.
  3. Chemical repellents as a supplement: Use age-appropriate repellents when physical barriers alone are insufficient, particularly during outdoor activities in high-risk areas.

The Nemours KidsHealth resource on mosquito-borne diseases emphasises that prevention is entirely in parents' hands, given the absence of paediatric vaccines for most mosquito-borne diseases in Europe.

Frequently Asked Questions

At what age can I use mosquito repellent on my child?

Most health authorities advise against using chemical repellents on infants under 2 months of age. For children aged 2 months to 3 years, use low-concentration products sparingly on exposed skin only. Always follow the specific product's age recommendations.

Are mosquito-borne diseases dangerous for children?

Yes. Children face higher risks of severe dengue, and immunocompromised children are vulnerable to neuroinvasive West Nile virus. Chikungunya can cause significant acute illness in children. Prevention through bite avoidance is critical.

What is the best way to protect a baby from mosquitoes?

Physical barriers are the safest and most effective approach for babies: fine-mesh mosquito nets over cribs and pushchairs, window and door screens in the home, and lightweight clothing covering arms and legs.


About Mosticare: Mosticare develops chemical-free mosquito protection solutions for homes, businesses, and communities across Europe. Our mission: a green, mosquito-free life for every European. Learn more

Sources cited in this article:

  1. ECDC - World Mosquito Day 2025: Europe sets new records
  2. WHO Europe - Public health advice on mosquito-borne diseases
  3. ECDC - Mosquito-borne diseases: an increasing risk in Europe
  4. International Journal of Clinical Pediatrics - Mosquito-borne diseases and their impact on children
  5. Nemours KidsHealth - Mosquito-borne diseases
  6. FDA - IXCHIQ vaccine suspension